3 participants
CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-05-23
- Start Date:
- 2016-06-30
- Completion:
- 2016-11-30
Conditions
- Systemic Lupus Erythematosus
Interventions
- DRUG
No Results Yet